Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer-中国期刊网

摘要 Ovariancanceristhesecondmostlethalgynecologicalcancerworldwideandwhilemostpatientsrespondtoinitialtherapy,theyoftenrelapsewithresistantdisease.Humanepidermalgrowthfactorreceptors(especiallyHER1/EGFRandHER2/ERBB2)areinvolvedindiseaseprogression;hence,strategiestoinhibittheiractioncouldproveadvantageousinovariancancerpatients,especiallyinpatientsresistanttofirstlinetherapy.Monoclonalantibodiesandtyrosinekinaseinhibitorsaretwoclassesofdrugsthatactonthesereceptors.Theyhavedemonstratedvaluableantitumoractivityinmultiplecancersandtheirpossibleuseinovariancancercontinuestobestudied.Inthisreview,wediscussthehumanepidermalgrowthfactorreceptorfamily;reviewemergingclinicalstudiesonmonoclonalantibodiesandtyrosinekinaseinhibitorstargetingthesereceptorsinovariancancerpatients;andproposefutureresearchpossibilitiesinthisarea.

1Shen Le-Sang,Jin Xiao-Yan,Wang Xu-Meng,Tou Lai-Zhen,Huang Jian. Advances in endocrine and targeted therapy for hormone-receptorpositive, human epidermal growth factor receptor 2-negative advanced breast cancer.医药卫生,2020-08.
2Qian Zhong,Lifei wang,Meng Cheng,Hanshuo Yang. Fibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer.医药卫生,2022-12.
3YingLin ZhiduoLiu JianminJiang ZiqingJiang Yongyongji BingSun. Expression of Intracellular Domain of Epidermal Growth Factor Receptor and Generation of Its Monoclonal Antibody.免疫学,2004-02.
4俞小虹;程浩;郑伟. Expression of Activated Epidermal Growth Factor Receptor and Transcription Factor E2F in Condyloma Accuminata.皮肤病学与性病学,2003-01.
5Ying Xu,Changjun Wang,Yali Xu,Bo Pan,Qiang Sun. Changes in the detection of human epidermal growth factor receptor 2 gene (Her-2) status for Her-2 fluorescent in situ hybridization testing.医药卫生,2022-12.
6Ling Xin,Qian Wu,Chongming Zhan,Hongyan Qin,Hongyu Xiang,Ling Xu,Jingming Ye,Xuening Duan,Yinhua Liu,Chinese Society of Breast Surgery (CSBrS),Chinese Society of Surgery of Chinese Medical Association. Multicenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of Breast Surgery 021).医药卫生,2022-12.
7赖西南;王正国;魏立;王丽丽. Effect of substance P released from peripheral nerve ending on endogenous expression of epidermal growth factor and its receptor in wound healing.临床医学,2002-03.
8Teresa Kim;Rodabe N. Amaria;Christine Spencer;Alexandre Reuben;Zachary A. Cooper;Jennifer A.Wargo. Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.肿瘤,2014-04.
9Deng Hao,Zhu Hong-Lan,Li Yi,Wang Yue,Wu Yan,Cui Heng,Wang Jian-Liu,Li Xiao-Ping. Treatment of liver metastases in patients with epithelial ovarian cancer.医药卫生,2021-05.
10Mark N Stein. Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer.泌尿科学,2014-03.

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

来源期刊

相关推荐

同分类资源更多

相关关键词

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

来源期刊

相关推荐

同分类资源 更多

相关关键词

同分类资源更多